Weight-loss Injections

Achieve sustainable weight loss with MICB12 with GLP-1 medications – FDA-approved, scientifically proven to curb cravings and control appetite. Lose up to 15-20% of your body weight without extreme diets or intense workouts

Semaglutide+MICB12

$350

A powerful GLP-1 medication for weight loss.
Semaglutide is an FDA-approved treatment that mimics the body’s natural GLP-1 hormone to reduce appetite, improve blood sugar control, and support long-term weight loss. Available as Ozempic, Wegovy, and Rybelsus, it helps patients lose up to 15% of body weight while lowering A1C levels.

✔️ Once-weekly injection for convenience
✔️ Clinically proven to reduce cravings & appetite
✔️ Supports weight loss

Tirzepatide+MICB12

$600

The next-generation GLP-1 + GIP medication for maximum weight loss.
Tirzepatide is a dual-action weight loss and diabetes medication that activates GLP-1 and GIP receptors to enhance insulin regulation, suppress hunger, and accelerate weight loss. Sold under Mounjaro and Zepbound, it has shown to help patients lose up to 20% of their body weight—making it one of the most effective medical weight loss treatments available.

✔️ More effective than Semaglutide for weight loss
✔️ Targets two hunger-controlling hormones (GLP-1 + GIP)
✔️ Reduces A1C levels and supports metabolic health

unsplash-image-ZSpkUThb7qk.jpg

What Makes Our Weight Loss Injections Different?

Our clinically supervised GLP-1 therapy goes beyond standard treatments by including MIC B12 for enhanced fat loss, energy, and metabolism. Unlike other providers, we administer and closely monitor your treatment in-clinic, ensuring precise dosing, minimized side effects, and optimal results.

✔️ MIC B12 Boost – Enhances fat burning, prevents fatigue & supports metabolism
✔️ Clinically Supervised – Safe, personalized dosing with expert monitoring
✔️ Maximized Results – Science-backed weight loss with long-term success

Which one is better for you?

  • Semaglutide

    GLP-1 receptor agonist

    Tirzepatide

    Dual agonist (GLP-1 & GIP receptors)

  • Semaglutide

    Up to 15-20% of body weight

    Tirzepatide

    Up to 22.5% of body weight

  • Semaglutide

    Approved for type 2 diabetes (Ozempic) and weight loss (Wegovy)

    Tirzepatide

    Approved for type 2 diabetes (Mounjaro)

  • Semaglutide

    Nausea, stomach discomfort, possible pancreatitis risk

    Tirzepatide

    Nausea, diarrhea, vomiting (more GI side effects)

  • Semaglutide

    Approved for weight loss

    Tirzepatide

    Pending for weight loss

Combining MIC B12 with GLP-1 medications can enhance weight loss, boost energy, and support overall health. B12 improves energy levels and metabolism, helping to counteract fatigue from GLP-1 side effects and promoting fat breakdown. It also supports mood and cognitive function, reduces the risk of B12 deficiency, and complements GLP-1’s appetite suppression and fat-burning effects. This combination can lead to more sustainable weight loss and better overall well-being.